1. Zhou, Rong, Mawatari, Go, Cai, Xue-Bi, Nao-I, Nobuhisa, Jin, Zi-Bing. 2022. CLEC3B is a novel causative gene for macular-retinal dystrophy. In Genetics in medicine : official journal of the American College of Medical Genetics, 24, 1249-1260. doi:10.1016/j.gim.2022.02.012. https://pubmed.ncbi.nlm.nih.gov/35331648/
2. Chen, Zhoufeng, Zeng, Liuwei, Chen, Zhuoyan, Zeng, Yuan, Yu, Fujun. . Combined OLA1 and CLEC3B Gene Is a Prognostic Signature for Hepatocellular Carcinoma and Impact Tumor Progression. In Technology in cancer research & treatment, 23, 15330338241241935. doi:10.1177/15330338241241935. https://pubmed.ncbi.nlm.nih.gov/38564315/
3. Valdes, A M. 2010. Involvement of the CLEC3B gene in osteoarthritis. In Osteoarthritis and cartilage, 19, 249. doi:10.1016/j.joca.2010.09.012. https://pubmed.ncbi.nlm.nih.gov/21075210/
4. Xie, Xing-Wei, Jiang, Shan-Shan, Li, Xiang. 2021. CLEC3B as a Potential Prognostic Biomarker in Hepatocellular Carcinoma. In Frontiers in molecular biosciences, 7, 614034. doi:10.3389/fmolb.2020.614034. https://pubmed.ncbi.nlm.nih.gov/33553242/
5. Lu, Xiangjun, Shen, Jian, Huang, Siyuan, Wang, Haitao, Liu, Dongdong. 2022. Down-regulation of CLEC3B facilitates epithelial-mesenchymal transition, migration and invasion of lung adenocarcinoma cells. In Tissue & cell, 76, 101802. doi:10.1016/j.tice.2022.101802. https://pubmed.ncbi.nlm.nih.gov/35500520/
6. Liu, Jian, Liu, Zhe, Liu, Qun, Wen, Tao, An, Guangyu. 2018. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma. In Oncology reports, 40, 2023-2035. doi:10.3892/or.2018.6590. https://pubmed.ncbi.nlm.nih.gov/30066941/
7. Sun, Jiaxing, Xie, Tian, Jamal, Muhammad, Zhang, Qiuping, Huang, Xiaoxing. 2020. CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment. In Cancer cell international, 20, 106. doi:10.1186/s12935-020-01183-1. https://pubmed.ncbi.nlm.nih.gov/32265595/
8. Wu, Shengze, Wang, Guangfeng, Xie, Yuwei, Dong, Bingzi, Zhu, Chengzhan. 2024. The CLEC3B inhibits cellular proliferation and metastasis of cholangiocarcinoma through Wnt/β-catenin pathway. In PeerJ, 12, e18497. doi:10.7717/peerj.18497. https://pubmed.ncbi.nlm.nih.gov/39553729/
智鼠故事 
